BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 20975547)

  • 21. Disulfiram in context: structure and safety.
    Martin B; Beresford TP
    J Clin Psychopharmacol; 2007 Aug; 27(4):415-7; author reply 417-8. PubMed ID: 17632238
    [No Abstract]   [Full Text] [Related]  

  • 22. Comparing treatments of alcoholism on craving and biochemical measures of alcohol consumptionst.
    Nava F; Premi S; Manzato E; Lucchini A
    J Psychoactive Drugs; 2006 Sep; 38(3):211-7. PubMed ID: 17165363
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Manic episode with psychotic symptoms associated with high dose of disulfiram: a case report.
    Ceylan ME; Turkcan A; Mutlu E; Onal O
    J Clin Psychopharmacol; 2007 Apr; 27(2):224-5. PubMed ID: 17414256
    [No Abstract]   [Full Text] [Related]  

  • 24. Potentially fatal interaction between colchicine and disulfiram.
    Chen SC; Huang MC; Fan CC
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Oct; 33(7):1281. PubMed ID: 19580840
    [No Abstract]   [Full Text] [Related]  

  • 25. Sensitivity of commercial ethyl glucuronide (ETG) testing in screening for alcohol abstinence.
    Wojcik MH; Hawthorne JS
    Alcohol Alcohol; 2007; 42(4):317-20. PubMed ID: 17376784
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Naltrexone and disulfiram in patients with alcohol dependence and comorbid psychiatric disorders.
    Petrakis IL; Poling J; Levinson C; Nich C; Carroll K; Rounsaville B;
    Biol Psychiatry; 2005 May; 57(10):1128-37. PubMed ID: 15866552
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Disulfiram-induced punding.
    Fan CC; Lin SK; Huang MC
    J Clin Psychopharmacol; 2008 Aug; 28(4):473-4. PubMed ID: 18626287
    [No Abstract]   [Full Text] [Related]  

  • 28. Hepatitis C in alcohol dependence:drinking versus disulfiram.
    Kulig CC; Beresford TP
    J Addict Dis; 2005; 24(2):77-89. PubMed ID: 15784525
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Compliance with aftercare treatment, including disulfiram, and effect on outcome in alcohol-dependent patients.
    Neto D; Lambaz R; Tavares JE
    Alcohol Alcohol; 2007; 42(6):604-9. PubMed ID: 17878216
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of disulfiram and placebo in treatment of alcohol dependence of adolescents.
    Niederhofer H; Staffen W
    Drug Alcohol Rev; 2003 Sep; 22(3):295-7. PubMed ID: 15385223
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Urinary ethyl glucuronide and ethyl sulfate testing for detection of recent drinking in an outpatient treatment program for alcohol and drug dependence.
    Dahl H; Voltaire Carlsson A; Hillgren K; Helander A
    Alcohol Alcohol; 2011; 46(3):278-82. PubMed ID: 21339184
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of disulfiram for alcohol relapse prevention in patients in opioid maintenance treatment.
    Specka M; Heilmann M; Lieb B; Scherbaum N
    Clin Neuropharmacol; 2014; 37(6):161-5. PubMed ID: 25384073
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ethyl glucuronide (EtG): better than breathalyser or self-reports to detect covert short-term relapses into drinking.
    Wetterling T; Dibbelt L; Wetterling G; Göder R; Wurst F; Margraf M; Junghanns K
    Alcohol Alcohol; 2014; 49(1):51-4. PubMed ID: 24133131
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Urinary ethyl glucuronide (EtG) and ethyl sulphate (EtS) assessment: valuable tools to improve verification of abstention in alcohol-dependent patients during in-patient treatment and at follow-ups.
    Junghanns K; Graf I; Pflüger J; Wetterling G; Ziems C; Ehrenthal D; Zöllner M; Dibbelt L; Backhaus J; Weinmann W; Wurst FM
    Addiction; 2009 Jun; 104(6):921-6. PubMed ID: 19466918
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cutaneous reactions to lower aliphatic alcohols before and during disulfiram therapy.
    Haddock NF; Wilkin JK
    Arch Dermatol; 1982 Mar; 118(3):157-9. PubMed ID: 7065662
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Disulfiram treatment for alcoholism in severe mental illness.
    Mueser KT; Noordsy DL; Fox L; Wolfe R
    Am J Addict; 2003; 12(3):242-52. PubMed ID: 12851020
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute myocardial infarction due to disulfiram (antabus)-alcohol interaction.
    Altun G; Altun A; Erdogan O
    Cardiovasc Drugs Ther; 2006 Oct; 20(5):391-2. PubMed ID: 17119876
    [No Abstract]   [Full Text] [Related]  

  • 38. Problem drinking in relation to treatment outcome among opiate addicts in methadone maintenance treatment.
    Stenbacka M; Beck O; Leifman A; Romelsjö A; Helander A
    Drug Alcohol Rev; 2007 Jan; 26(1):55-63. PubMed ID: 17364837
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Mechanism of action of disulfiram and treatment optimization in prevention of recurrent alcoholism].
    Mutschler J; Kiefer F
    Praxis (Bern 1994); 2013 Jan; 102(3):139-46. PubMed ID: 23384983
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A one-year pragmatic trial of naltrexone vs disulfiram in the treatment of alcohol dependence.
    De Sousa A; De Sousa A
    Alcohol Alcohol; 2004; 39(6):528-31. PubMed ID: 15525790
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.